Abstract
BackgroundThe daily dose of oral glucocorticoids (OCS) is associated with damage in Systemic Lupus Erythematosus (SLE), and OCS reduction is a major goal of SLE care. However, evidence regarding the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have